ARCHIVES

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

NIH Reauthorization Threatened By Fetal Research Issue

October 5, 1990

In Brief: Chabner Says He ”Has No Intention Of Leaving NCI; “Yarbro Named Clinical Indicators Chairman

September 2, 1988

Patch-Lozenge Combination Best For Smoking Cessation

November 27, 2009

Industry Groups Lobby for Lower Standards for FDA Approval

November 18, 2011

Maxine Singer Wins Top SES Award

January 8, 1988

In Brief: Korsmeyer Wins Bristol-Meyers Squibb Award; Lichter Names President-Elect of ASCO

April 18, 1997